PLI schemes should also focus on entities supporting production of branded pharma products: Bharat Biotech https://ift.tt/sxItySL

Currently, the government through the Department of Pharmaceuticals (DoP) is currently implementing three PLI schemes -- Bulk Drugs (Rs 6,940 crore), Medical Devices (Rs 3,420 crore) and Pharmaceuticals (Rs 15,000 crore) -- to promote manufacturing activity. Prasad noted that the domestic pharma sector should "focus upon innovation."

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/i5xnszc